Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Humoral and cellular correlates of a novel immune-related adverse event and its treatment.
J Immunother Cancer. 2021 Dec;9(12):e003585. doi: 10.1136/jitc-2021-003585.
J Immunother Cancer. 2021.
PMID: 34880115
Free PMC article.
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
Mu-Mosley H, Ostermann L, Muftuoglu M, Vaidya A, Bonifant CL, Velasquez MP, Gottschalk S, Andreeff M.
Mu-Mosley H, et al.
Front Immunol. 2022 May 9;13:880108. doi: 10.3389/fimmu.2022.880108. eCollection 2022.
Front Immunol. 2022.
PMID: 35615350
Free PMC article.
Item in Clipboard
Distinct autoantibody profiles across checkpoint inhibitor types and toxicities.
Mu-Mosley H, von Itzstein MS, Fattah F, Liu J, Zhu C, Xie Y, Wakeland EK, Park JY, Kahl BS, Diefenbach CS, Gerber DE.
Mu-Mosley H, et al.
Oncoimmunology. 2024 May 9;13(1):2351255. doi: 10.1080/2162402X.2024.2351255. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38737792
Free PMC article.
Clinical Trial.
Item in Clipboard
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.
Jia Y, Zhang W, Basyal M, Chang KH, Ostermann L, Burks JK, Ly C, Mu-Mosley H, Zhang Q, Han X, Fogler WE, Magnani JL, Lesegretain A, Zal AA, Zal T, Andreeff M.
Jia Y, et al. Among authors: mu mosley h.
Leukemia. 2023 Jun;37(6):1379-1383. doi: 10.1038/s41375-023-01897-x. Epub 2023 Apr 21.
Leukemia. 2023.
PMID: 37085610
Free PMC article.
No abstract available.
Item in Clipboard
Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study.
Ulndreaj A, Brinc D, Altan M, Pons-Belda OD, Fernandez-Uriarte A, Mu-Mosley H, Fattah F, von Itzstein MS, Soosaipillai A, Kulasingam V, Palaskas NL, Gerber DE, Diamandis EP, Heymach JV, Prassas I.
Ulndreaj A, et al. Among authors: mu mosley h.
Clin Chem Lab Med. 2022 Oct 27;61(1):154-161. doi: 10.1515/cclm-2022-0471. Print 2023 Jan 27.
Clin Chem Lab Med. 2022.
PMID: 36287134
Item in Clipboard
Cite
Cite